Covid-19 roundup: EU cracks down fur­ther on vac­cine ex­ports; Pfiz­er en­ters race for Covid-19 pill

Eu­rope is lock­ing down its bor­ders again.

Strug­gling to in­oc­u­late its pop­u­la­tion while the UK and US steam­roll ahead, the Eu­ro­pean Union is fi­nal­iz­ing leg­is­la­tion that would give it broad pow­er to pre­vent vac­cines pro­duced in its bor­ders from leav­ing its bor­ders for six weeks, The New York Times re­port­ed.

The crack­down on ex­ports could most se­vere­ly im­pact the UK. The for­mer EU mem­ber state con­tract­ed with As­traZeneca and lat­er Pfiz­er and BioN­Tech to buy mil­lions of dos­es that are pro­duced on the con­ti­nent — dos­es they’ve been re­ly­ing on to now vac­ci­nate 40% of its pop­u­la­tion. On­ly about 10% of the EU’s pop­u­la­tion have re­ceived shots.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER